Evidence map›Paper›PMID 36749637›Full record

ArticleJCI insight2023

Adipose-targeted SWELL1 deletion exacerbates obesity- and age-related nonalcoholic fatty liver disease.

Susheel K Gunasekar, John Heebink, Danielle H Carpenter, Ashutosh Kumar, Litao Xie, Haixia Zhang, Joel D Schilling, Rajan Sah

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Mechanosensing in Metabolism.Comprehensive Physiology · 2023
    Review
  10. [The regulation of APGAT4 on the growth and lenvatinib resistance of hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Susheel K GunasekarDepartment of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri, USA.
John HeebinkDepartment of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri, USA.
Danielle H CarpenterDepartment of Pathology, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
Ashutosh KumarDepartment of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri, USA.
Litao XieDepartment of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri, USA.
Haixia ZhangDepartment of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri, USA.
Joel D SchillingDepartment of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri, USA.
Rajan SahDepartment of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri, USA.
Washington University in St. Louis · USSaint Louis University · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
Tuning fat cell size and obesity through SWELL1R01DK106009 · NIDDK · WASHINGTON UNIVERSITY · PI SAH, RAJAN · 2016 to 2024
$3.8M
Harnessing macrophage lysosomal lipid metabolism in obesity-associated diseasesR01DK131188 · NIDDK · WASHINGTON UNIVERSITY · PI MITTENDORFER, BETTINA, RAZANI, BABAK · 2022 to 2025
$2.6M
Optimizing small molecule SWELL1-LRRC8 modulators to treat Type 2 diabetesR01DK126068 · NIDDK · WASHINGTON UNIVERSITY · PI SAH, RAJAN · 2021 to 2025
$2.0M
SWELL1-LRRC8 mediated regulation of skeletal muscle function and metabolismR01DK127080 · NIDDK · WASHINGTON UNIVERSITY · PI SAH, RAJAN · 2021 to 2024
$1.7M
Ion channel regulation of pancreatic islet cell functionI01BX005072 · VA · ST. LOUIS VA MEDICAL CENTER · PI SAH, RAJAN · 2020 to 2023
–
BLRD VA I01 BX005072NCATS NIH HHS UL1 TR002345NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056341NIDDK NIH HHS R01 DK106009NIDDK NIH HHS R01 DK126068NIDDK NIH HHS R01 DK127080NIDDK NIH HHS R01 DK131188
6 · The paper itself

Abstract

Healthy expansion of adipose tissue is critical for the maintenance of metabolic health, providing an optimized reservoir for energy storage in the form of triacylglycerol-rich lipoproteins. Dysfunctional adipocytes that are unable to efficiently store lipid can result in lipodystrophy and contribute to nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome. Leucine-rich repeat containing protein 8a/SWELL1 functionally encodes the volume-regulated anion channel complex in adipocytes, is induced in early obesity, and is required for normal adipocyte expansion during high-fat feeding. Adipose-specific SWELL1 ablation (Adipo KO) leads to insulin resistance and hyperglycemia during caloric excess, both of which are associated with NAFLD. Here, we show that Adipo-KO mice exhibited impaired adipose depot expansion and excess lipolysis when raised on a variety of high-fat diets, resulting in increased diacylglycerides and hepatic steatosis, thereby driving liver injury. Liver lipidomic analysis revealed increases in oleic acid-containing hepatic triacylglycerides and injurious hepatic diacylglyceride species, with reductions in hepatocyte-protective phospholipids and antiinflammatory free fatty acids. Aged Adipo-KO mice developed hepatic steatosis on a regular chow diet, and Adipo-KO male mice developed spontaneous, aggressive hepatocellular carcinomas (HCCs). These data highlight the importance of adipocyte SWELL1 for healthy adipocyte expansion to protect against NAFLD and HCC in the setting of overnutrition and with aging.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsNon-alcoholic Fatty Liver DiseaseAnimalsDiet, High-FatGlucoseMaleMembrane ProteinsMiceObesityGlucoseLRRC8A protein, mouseMembrane ProteinsAdipose tissueGlucose metabolismHepatologyLiver cancerMetabolism

Identifiers

PMID36749637
PMCPMC10077479
OpenAlexW4319334018

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.